Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapy

Molecular Cancer Therapeutics

Volumn 8, Issue 11, 2009, Pages 3098-3107

  Martinez Quintanilla, Jordi ^a   Cascallo, Manel ^a   Gros, Alena ^a   Fillat, Cristina ^b   Alemany, Ramon ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b CENTRE FOR GENOMIC REGULATION CRG   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; GANCICLOVIR; MULTIDRUG RESISTANCE PROTEIN 1; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BYSTANDER EFFECT; CELL SELECTION; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SENSITIZATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUICIDE GENE THERAPY;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; GANCICLOVIR; GENE THERAPY; GENES, TRANSGENIC, SUICIDE; GENETIC VECTORS; HUMANS; MALE; MICE; MICE, INBRED BALB C; P-GLYCOPROTEIN; PANCREATIC NEOPLASMS; TAXOIDS; THYMIDINE KINASE; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 70949103705     PISSN: 15357163     EISSN: None     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-09-0350     Document Type: Article

References (35)

1. Konig J, Hartel M, Nies AT, et al. Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int J Cancer 2005;115:359-367 (Pubitemid 40663738)
2. Hutterer M, Gunsilius E, Stockhammer G. Molecular therapies for malignant glioma. Wien Med Wochenschr 2006;156:351-363
3. Fillat C, Carrio M, Cascante A, Sangro B. Suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene/ganciclovir system: fifteen years of application. Curr Gene Ther 2003;3:13-26.
4. Freeman SM, Abboud CN, Whartenby KA, et al. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 1993;53:5274-5283
5. Cascante A, Huch M, Rodriguez LG, Gonzalez JR, Costantini L, Fillat C. Tat8-TK/GCV suicide gene therapy induces pancreatic tumor regression in vivo. Hum Gene Ther 2005;16:1377-1388 (Pubitemid 41829013)
6. Smitt PS, Driesse M, Wolbers J, Kros M, Avezaat C. Treatment of relapsed malignant glioma with an adenoviral vector containing the herpes simplex thymidine kinase gene followed by ganciclovir. Mol Ther 2003;7: 851-858 (Pubitemid 36790262)
7. Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C. Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 2007;67:6304-6313 (Pubitemid 47037513)
8. Fritz V, Jorgensen C. Mesenchymal stem cells: an emerging tool for cancer targeting and therapy. Curr Stem Cell Res Ther 2008;3:32-42. (Pubitemid 352024865)
9. Unger MM, Wahl J, Ushmorov A, et al. Enriching suicide gene bearing tumor cells for an increased bystander effect. Cancer Gene Ther 2007;14: 30-38 (Pubitemid 44952231)
10. Martinez-Quintanilla J, Cascallo M, Fillat C, Alemany R. Antitumor Therapy Based on Cellular Competition. Hum Gene Ther 2009;20:728-738
11. Rougier P, Adenis A, Ducreux M, et al. A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma. Eur J Cancer 2000;36:1016-1025 (Pubitemid 30316427)
12. Liu B, Staren ED, Iwamura T, Appert HE, Howard JM. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma. J Surg Res 2001;99:179-186 (Pubitemid 32703435)
13. Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res 1970;30:1174-1184
14. Lu Z, Kleeff J, Shrikhande S, et al. Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer. Pancreas 2000;21:240-247 (Pubitemid 30749099)
15. Zalatnai A. P-glycoprotein expression is induced in human pancreatic cancer xenografts during treatment with a cell cycle regulator, mimosine. Pathol Oncol Res 2005;11:164-169 (Pubitemid 41564563)
16. D'Hondt V, Symann M, Machiels JP. Chemoprotection and selection by chemotherapy of multidrug resistance-associated protein-1 (MRP1) transduced cells. Curr Gene Ther 2001;1:359-366
17. Sugimoto Y, Hrycyna CA, Aksentijevich II, Pastan II, Gottesman MM. Coexpression of a multidrug-resistance gene (MDR1) and herpes simplex virus thymidine kinase gene as part of a bicistronic messenger RNA in a retrovirus vector allows selective killing of MDR1-transduced cells. Clin Cancer Res 1995;1:447-457
18. Schondorf T, Neumann R, Benz C, et al. Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines. Recent Results Cancer Res 2003;161:111-116
19. Villanueva A, Garcia C, Paules AB, et al. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells. Oncogene 1998;17:1969-1978 (Pubitemid 28488465)
20. Petriz J, Gottesman MM, Aran JM. An MDR-EGFP gene fusion allows for direct cellular localization, function and stability assessment of P-glycoprotein. Curr Drug Deliv 2004;1:43-56.
21. Ishida Y, Ohtsu T, Hamada H, et al. Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16. Jpn J Cancer Res 1989;80:1006-1013 (Pubitemid 20028818)
22. Kucerova L, Matuskova M, Pastorakova A, et al. Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice. J Gene Med 2008;10:1071-1082
23. Erbs P, Findeli A, Kintz J, et al. Modified vaccinia virus Ankara as a vector for suicide gene therapy. Cancer Gene Ther 2008;15:18-28. (Pubitemid 350261298)
24. Varghese S, Rabkin SD. Oncolytic herpes simplex virus vectors for cancer virotherapy. Cancer Gene Ther 2002;9:967-978 (Pubitemid 35462560)
25. Chua YJ, Cunningham D. Chemotherapy for advanced pancreatic cancer. Best Pract Res Clin Gastroenterol 2006;20:327-348
26. Bergman AM, Pinedo HM, Veerman G, Kuiper CM, Peters GJ. Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell lines. Adv Exp Med Biol 1998;431: 591-594 (Pubitemid 28236842)
27. Carrio M, Visa J, Cascante A, Estivill X, Fillat C. Intratumoral activation of cyclophosphamide by retroviral transfer of the cytochrome P450 2B1 in a pancreatic tumor model. Combination with the HSVtk/GCV system. J Gene Med 2002;4:141-149 (Pubitemid 40277164)
28. Denny WA. Prodrugs for gene-directed enzyme-prodrug therapy (suicide gene therapy). J Biomed Biotechnol 2003;2003:48-70. (Pubitemid 36828274)
29. Andrade-Rozental AF, Rozental R, Hopperstad MG, Wu JK, Vrionis FD, Spray DC. Gap junctions: the "kiss of death" and the "kiss of life". Brain Res Brain Res Rev 2000;32:308-315
30. Burrows FJ, Gore M, Smiley WR, et al. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Cancer Gene Ther 2002;9:87-95.
31. Schaller BJ, Cornelius JF, Sandu N, Buchfelder M. Molecular imaging of brain tumors personal experience and review of the literature. Curr Mol Med 2008;8:711-726
32. Mayer-Kuckuk P, Banerjee D, Malhotra S, et al. Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression. Proc Natl Acad Sci U S A 2002;99:3400-3405 (Pubitemid 34252121)
33. Papapetrou EP, Ziros PG, Micheva ID, Zoumbos NC, Athanassiadou A. Gene transfer into human hematopoietic progenitor cells with an episomal vector carrying an S/MAR element. Gene Ther 2006;13:40-51. (Pubitemid 41823850)
34. Liu H, Visner GA. Applications of Sleeping Beauty transposons for nonviral gene therapy. IUBMB Life 2007;59:374-379 (Pubitemid 47027112)
35. Reszka RC, Jacobs A, Voges J. Liposome-mediated suicide gene therapy in humans. Methods Enzymol 2005;391:200-208 (Pubitemid 40254037)